Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times

Cytometry

Volumn 28, Issue 4, 1997, Pages 280-288

  Dong, Hangying ^a   Bertler, Carey ^a   Schneider, Eric ^a   Ritter, Mark A ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

AgNOR; Cell proliferation; Flow cytometry; Immunohistochemistry; Ki 67; Potential doubling time

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTROGEN; KI 67 ANTIGEN; PYRIMIDINE; SILVER NITRATE;

ANTIGEN DETECTION; ARTICLE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; DIAGNOSTIC VALUE; HALOGENATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; NUTRITIONAL STATUS; PRIORITY JOURNAL; SCORING SYSTEM; TUMOR BIOPSY;

CELL DIVISION; ESTROGEN ANTAGONISTS; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; SERUM ALBUMIN, BOVINE; SILVER NITRATE; SILVER STAINING; TAMOXIFEN; TIME FACTORS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030742690     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970801)28:4<280::AID-CYTO2>3.0.CO;2-G     Document Type: Article

References (41)

1. Begg AC, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Le Fur R, Van Den Bogaert W, Caspers R, Van Glabbeke M, et al.: The predictive value of cell kinetic measurements in a European trial of accelerated fractionation In advanced head and neck tumors: An interim report, Int J Radiat Oncol Biol Phys 19:1449-1453, 1990.
2. Begg AC, Hofland I, Van Glabekke M, Bartelink H, Horiot JC: Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC Cooperative Trial 22851. Sem Radiat Oncol 2:22-25, 1992.
3. Begg AC, Hofland I, Kummermehr J: Tumour cell repopulation during fractionated radiotherapy: Correlation between flow cytometric and radiobiologlcal data in three murine tumours. Eur J Cancer 27:537-543, 1991.
4. Begg AC, McNally NJ, Schrieve DC, Karcher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6:620-626, 1985.
5. Biesterfeld S, Striepecke E, Bocking A: Single-cell-based quantification of the proliferation fraction by image analysis. Virchows Arch 427:339, 1995.
6. Brown DC, Gatter KC: Monoclonal antibody Ki-67: Its use in histopathology. Histopathology 17:489-503, 1990.
7. Corvo R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Guenzi M, Margarine) G, Bacigalupo A, Garaventa G, Barbieri M, Vitale V: In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. I Clin Oncol 13:1843-1850, 1995.
8. Cracker J, Macartney JC, Smith PJ: Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol 154:151-156, 1988.
9. Crocker J, Nar P: Nucleolar organizer regions in lymphomas. J Pathol 151:111-118, 1987.
10. Dervan PA, Gilmartin LG, Loftus BM, Carney DN: Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores. Am J Clin Pathol 92:401-407. 1989,
11. Dolbeare F; Bromodeoxyuridine: A diagnostic tool in biology and medicine. Part I: Historical perspectives, histochemical methods and cell kinetics, Histochem J 27:339-369. 1995.
12. Fowler JF: Potential for increasing the differential response between tumors and normal tissues: Can proliferation rate he used? Int I Radiat Oncol Biol Phys 12:641-645, 1986.
13. Hamilton PW: Nucleolar organizer regions. In: Quantitative Clinical Pathology, Hamilton PW, Allen DC (eds), Cambridge, UK: Blackwell Science, 1995, pp 127-139.
14. Hittmair A, Ofner D, Offner F, Feichtinger H, Ensinger C, Gogatsch H, Mikuz G: In vitro investigations of interphase and metaphase argyrophilic nucleolar organizer regions and cellular proliferation in the human urothelial cancer cell line HOK-1. Virchows Archiv 424:149-154, 1994.
15. Howat AJ, Giri DD, Cotton DWK, Slater DN: Nucleolar organizer regions in spitz nevi and malignant melanomas. Cancer 63:474-478, 1989.
16. Jordan VC, Collins MM, Rowsby L, Prestwich G: A monohydroxylated metabolite of tamoxifen with potent anticstrogenic activity. J Endocrinol 75:305-316, 1977.
17. Kakeji Y, Korenaga D, Tsujitani S, Haraguchi M, Maehara Y, Sugimachi K: Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer. Cancer Res 51:3503-3506, 1991.
18. Kreipe H, Zeidler R, Fischer L, Feist H: Immunocytochemical assessment of cell proliferation. Virchows Arch 427:324-326, 1995.
19. Lindner LE: Improvement in the silver-staining technique for nucleolar organizer regions (AgNOR). J Histochem Cytochem 41:439-445, 1993.
20. Lindstrom MJ, Fowler JF: Re-analysis of the time factor in local control by radiotherapy of T3T4 squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 21:813-817, 1991.
21. Marmont F, Pich A, Chiusa L, Locatclli F, Falda M, Boccadoro M, Resegotti L: Correlation between argyrophillc nucleolar organizer region counts and labeling index in multiple myeloma. Eur J Haematol 56:39-44, 1996.
22. Oka K, Arai T: MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy. Int J Gynecol Pathol 15:23-27, 1996.
23. Ploton D, Bobichon H, Adnet JJ: Ultrastructural localization of NOR in nucleoli of human breast cancer tissues using a one-step Ag-NOR staining method. Biol Cell 43:229-232, 1982.
24. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnet JJ: Improvement in the staining and in the visualization of the argyrophllic proteins of the nucleolar organizer region at the optical level. Histochem J 18:5-14, 1986.
25. Rago R, Mitchen J, Wilding G: DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal Biochem 191:31-34, 1990.
26. Ritter MA, Albrechtson JA, Kim YJ, Kinsella TJ: Tumor cell kinetics in mixed populations. Cytometry 16:118-128, 1994.
27. Ritter MA, Fowler J, Kim YJ, Lindstrom M, Kinsella TJ: Single biopsy, tumor kinetic analyses: A comparison of methods and an extension to shorter sampling intervals. Int I Radiat Oncol Biol Phys 23:811-820, 1992.
28. pot) of MCF-7 xenografts as determined by bromodeoxyuridine labeling and flow cytometry. Cancer Res 53:4413-4417, 1993.
29. Scott RJ, Hall PA, Haldane JS, van Noorden S, Price Y, Lane DP, Wright NA: A comparison of immunohistochemical markers of cell proliferation with experimentlly determined growth fraction. J Pathol 165:173-178, 1991.
30. Shiina H, Urakami S, Shirakawa H, Shigeno K, Himeno Y, Mizutani M, Igawa M, Ishibe T: Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer. Eur Urol 29:99-105, 1996.
31. Skalova A, Lehtonen H, von Boguslawsky K, Leivo I: Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: Clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 25:929-935, 1994.
32. Steck K, El-Naggar AK: Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Cytometry 17:258-265, 1994.
33. Tinnemans MMFJ, Lenders M-HJH, ten Velde GPM, Blijham GH, Ramaekers FCS, Schutte B: S-phase arrest of nutrient deprived lung cancer cells. Cytometry 19:326-333, 1995.
34. pot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkins's lymphoma. Exper Hematol 24:807-815, 1996.
35. Van Dierendonck JH, Keijzer R, Van de Velde CJH, Cornelisse CJ: Nuclear distribution of the Ki-67 antigen during the cell cycle: Comparison with growth fraction in human breast cancer cells. Cancer Res 49:2999-3006, 1989.
36. Verheijen R, Kuijpers HJH, van Driel R, Beck JLM, van Dierendonck JH, Brakenhoff GJ, Ramaekers FCS: Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Location in mitotic cells and association with chromosomes. J Cell Sci 92:531-540,1989.
37. White RA, Terry NHA, Meistrich ML Calkins DP: Improved method for computing potential doubling time from flow cytometric data. Cytometry 11:314-317, 1990.
38. Wilson GD: Assessment of human tumour proliferation using bromodeoxyuridine - current status. Acta Oncol 30:903-910, 1991.
39. pot) in human colorectal cancers. Br J Cancer 67:754-759, 1993.
40. Withers HR, Taylor JM, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-146, 1988.
41. Wozniak ZM, Usson Y, Parazza F, Champelovier P, Leroux D, Seigneurin D: Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells, Cytometry 24:14-26, 1996.